PL2007391T3 - Kombinacja zawierająca A) pirymidyloaminobenzamid i B) inhibitor kinazy THR315LLE - Google Patents
Kombinacja zawierająca A) pirymidyloaminobenzamid i B) inhibitor kinazy THR315LLEInfo
- Publication number
- PL2007391T3 PL2007391T3 PL07727881T PL07727881T PL2007391T3 PL 2007391 T3 PL2007391 T3 PL 2007391T3 PL 07727881 T PL07727881 T PL 07727881T PL 07727881 T PL07727881 T PL 07727881T PL 2007391 T3 PL2007391 T3 PL 2007391T3
- Authority
- PL
- Poland
- Prior art keywords
- thr315lle
- combination
- kinase inhibitor
- pyrimidylaminobenzamide compound
- pyrimidylaminobenzamide
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 229940043355 kinase inhibitor Drugs 0.000 title 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79043806P | 2006-04-07 | 2006-04-07 | |
| US79115006P | 2006-04-11 | 2006-04-11 | |
| PCT/EP2007/053413 WO2007116029A2 (en) | 2006-04-07 | 2007-04-05 | Combination comprising a) a pyrimidylaminobenzamide compound, and b) a thr315lle kinase inhibitor |
| EP07727881.0A EP2007391B8 (en) | 2006-04-07 | 2007-04-05 | Combination comprising a) a pyrimidylaminobenzamide compound, and b) a thr315ile kinase inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2007391T3 true PL2007391T3 (pl) | 2013-05-31 |
Family
ID=38229305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07727881T PL2007391T3 (pl) | 2006-04-07 | 2007-04-05 | Kombinacja zawierająca A) pirymidyloaminobenzamid i B) inhibitor kinazy THR315LLE |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20090286803A1 (pl) |
| EP (2) | EP2007391B8 (pl) |
| JP (2) | JP2009532440A (pl) |
| KR (1) | KR20090023561A (pl) |
| AU (1) | AU2007235900A1 (pl) |
| BR (1) | BRPI0710496A2 (pl) |
| CA (1) | CA2647803C (pl) |
| ES (1) | ES2400375T3 (pl) |
| MX (1) | MX2008012971A (pl) |
| PL (1) | PL2007391T3 (pl) |
| PT (1) | PT2007391E (pl) |
| RU (2) | RU2481840C2 (pl) |
| WO (1) | WO2007116029A2 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8217045B2 (en) * | 2007-04-17 | 2012-07-10 | Novartis Ag | Organic compounds |
| JO3265B1 (ar) | 2008-12-09 | 2018-09-16 | Novartis Ag | مثبطات بيريديلوكسى اندولات vegf-r2 واستخدامها لعلاج المرض |
| MX2012005023A (es) * | 2009-10-30 | 2012-06-19 | Ariad Pharma Inc | Metodos y composiciones para tratar cancer. |
| CN102822141A (zh) * | 2010-01-20 | 2012-12-12 | 普罗诺瓦生物医药挪威公司 | 水杨酸脂肪酸衍生物 |
| CN109730996B (zh) * | 2017-03-01 | 2021-08-24 | 浙江大学 | 喹啉结构类型雄激素受体拮抗剂及其应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002068415A1 (en) | 2000-12-21 | 2002-09-06 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| AU2002337410A1 (en) * | 2001-09-05 | 2003-03-18 | Oncopharm Corporation | Treatment of chronic myelogenous leukemia, resistant or intolerant to sti571, involving homoharringtonine alone or combined with other agents |
| EP1578346A4 (en) * | 2001-12-04 | 2007-11-28 | Onyx Pharma Inc | INHIBITORS OF THE RAF-MEK-ERK PATHWAY TO TREAT CANCER |
| AR037647A1 (es) | 2002-05-29 | 2004-12-01 | Novartis Ag | Derivados de diarilurea utiles para el tratamiento de enfermedades dependientes de la cinasa de proteina |
| FR2841116B1 (fr) | 2002-06-19 | 2004-11-26 | Seb Sa | Cafetiere du type expresso a reservoir d'eau amovible |
| GB0215676D0 (en) | 2002-07-05 | 2002-08-14 | Novartis Ag | Organic compounds |
| AU2003270668A1 (en) * | 2002-09-19 | 2004-04-08 | University Of South Florida | Method of treating leukemia with a combination of suberoylanilide hydromaxic acid and imatinib mesylate |
| DE10330916A1 (de) | 2003-07-04 | 2005-02-03 | Pilz Gmbh & Co. Kg | Vorrichtung und Verfahren zum automatisierten Steuern eines Betriebsablaufs bei einer technischen Anlage |
| US7338957B2 (en) | 2003-08-28 | 2008-03-04 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
| RU2401265C2 (ru) | 2004-06-10 | 2010-10-10 | Айрм Ллк | Соединения и композиции в качестве ингибиторов протеинкиназы |
| KR20070050918A (ko) * | 2004-07-02 | 2007-05-16 | 뉴텍 파마 피엘씨 | 암의 치료 |
| PE20060664A1 (es) | 2004-09-15 | 2006-08-04 | Novartis Ag | Amidas biciclicas como inhibidores de cinasa |
| GB0421525D0 (en) * | 2004-09-28 | 2004-10-27 | Novartis Ag | Inhibitors of protein kineses |
| WO2007056023A2 (en) * | 2005-11-02 | 2007-05-18 | Targegen, Inc. | Thiazole inhibitors targeting resistant kinase mutations |
-
2007
- 2007-04-05 JP JP2009503595A patent/JP2009532440A/ja active Pending
- 2007-04-05 EP EP07727881.0A patent/EP2007391B8/en not_active Not-in-force
- 2007-04-05 KR KR1020087027200A patent/KR20090023561A/ko not_active Ceased
- 2007-04-05 RU RU2008143704/15A patent/RU2481840C2/ru not_active IP Right Cessation
- 2007-04-05 ES ES07727881T patent/ES2400375T3/es active Active
- 2007-04-05 AU AU2007235900A patent/AU2007235900A1/en not_active Abandoned
- 2007-04-05 PL PL07727881T patent/PL2007391T3/pl unknown
- 2007-04-05 MX MX2008012971A patent/MX2008012971A/es active IP Right Grant
- 2007-04-05 EP EP12197654.2A patent/EP2574340A3/en not_active Withdrawn
- 2007-04-05 PT PT77278810T patent/PT2007391E/pt unknown
- 2007-04-05 BR BRPI0710496-0A patent/BRPI0710496A2/pt not_active IP Right Cessation
- 2007-04-05 CA CA2647803A patent/CA2647803C/en not_active Expired - Fee Related
- 2007-04-05 WO PCT/EP2007/053413 patent/WO2007116029A2/en not_active Ceased
- 2007-04-05 US US12/295,812 patent/US20090286803A1/en not_active Abandoned
-
2013
- 2013-01-29 RU RU2013103746/15A patent/RU2013103746A/ru unknown
- 2013-06-05 JP JP2013119191A patent/JP2013224304A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2400375T8 (es) | 2013-09-10 |
| EP2007391B8 (en) | 2013-05-29 |
| CA2647803C (en) | 2014-05-27 |
| PT2007391E (pt) | 2013-03-11 |
| EP2574340A2 (en) | 2013-04-03 |
| MX2008012971A (es) | 2008-10-15 |
| RU2008143704A (ru) | 2010-05-20 |
| KR20090023561A (ko) | 2009-03-05 |
| EP2007391B1 (en) | 2012-12-19 |
| WO2007116029A3 (en) | 2008-12-11 |
| BRPI0710496A2 (pt) | 2011-08-16 |
| EP2574340A3 (en) | 2013-04-17 |
| CA2647803A1 (en) | 2007-10-18 |
| EP2007391A2 (en) | 2008-12-31 |
| JP2009532440A (ja) | 2009-09-10 |
| WO2007116029A2 (en) | 2007-10-18 |
| ES2400375T3 (es) | 2013-04-09 |
| RU2481840C2 (ru) | 2013-05-20 |
| AU2007235900A1 (en) | 2007-10-18 |
| RU2013103746A (ru) | 2014-08-10 |
| JP2013224304A (ja) | 2013-10-31 |
| US20090286803A1 (en) | 2009-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL197381A0 (en) | Kinase inhibitor | |
| PL2079727T3 (pl) | Inhibitory kinazy | |
| IL190078A0 (en) | Kinase inhibitors | |
| ZA200900109B (en) | Pyrrolotriazine kinase inhibitors | |
| EP1794137A4 (en) | SPECIFIC KINASE INHIBITORS | |
| PL2402317T3 (pl) | Inhibitor DGAT | |
| IL179398A0 (en) | Dpp-ib inhibitors | |
| IL183276A0 (en) | Kinase inhibitors | |
| SI1943243T1 (sl) | Inhibotorji kinaz | |
| IL195331A0 (en) | Hsp90 inhibitor | |
| ZA200607648B (en) | Kinase inhibitors | |
| IL188850A0 (en) | Cathepsin k inhibitors | |
| PL2007391T3 (pl) | Kombinacja zawierająca A) pirymidyloaminobenzamid i B) inhibitor kinazy THR315LLE | |
| TWM299071U (en) | Hole saw | |
| EP2038304A4 (en) | BST2 INHIBITORS | |
| GB0421355D0 (en) | Inhibitors | |
| ZA200908943B (en) | Pyrazolopyrimidinone kinase inhibitor | |
| IL197981A0 (en) | Kinase inhibitors | |
| GB0603522D0 (en) | Kinase inhibition | |
| GB0421356D0 (en) | Inhibitors | |
| PL1917655T3 (pl) | System z korpusem świecącym oraz korpus świecący do systemu z korpusem świecącym | |
| GB0608854D0 (en) | P13 kinase inhibitors | |
| EP2076490A4 (en) | INHIBITORS OF CATHEPSIN B | |
| GB0516967D0 (en) | Inhibitors | |
| ZA200809814B (en) | HSP90 Inhibitor |